Fig. 7.
Association of risk score and clinical characteristics (A–D). No significant difference was identified in patients with different age (A), sex (B), MGMT status (C) and between primary and recurrent glioma(D). Independence analysis of the risk model (E–J). Survival curve of patients regrouped according to age (E,F), sex (G,H), and metastasis (I,J). The risk score of constructed risk model was an independent predictive marker for glioma patients(K).
